InvestorsHub Logo

Trademanager

12/19/17 8:43 AM

#104355 RE: MIKEY501 #104352

12/19/17UPdate NSAV NEW-Partner ELI LILLY + TigerHemp Beer

https://ih.advfn.com/p.php?pid=nmona&article=76297985

https://www.otcmarkets.com/stock/NSAV/news/NSAV-Subsidiary-Signs-Major-Agreement-With-Eli-Lilly-and-Company?id=178156&b=y

******Copie of Contract*******
nsavholdinginc.com/files/VSRI-Eli-Lilly.pdf …
http://nsavholdinginc.com/files/VSRI-Eli-Lilly.pdf

**How much revenue is here possible for VSRI in this cooperation between VSRI and ELI LILLY $ Co if the market in China, treating diabetes and related diseases every year,
on annual basis is $ 50 billion ???


Shanghai based Vital Strategic Research Institute (VSRI), has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China
https://globenewswire.com/news-release/2017/10/11/1144375/0/en/NSAV-ANNOUNCES-CLOSING-OF-ACQUISITION-OF-SHANGHAI-VITAL-STRATEGIC-MEDICAL-TECHNOLOGY-COMPANY.html

NSAV SUBSIDIARY SIGNS MAJOR AGREEMENT WITH ELI LILLY & COMPANY
Eli Lilly and Company is a global pharmaceutical company
headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.
Shanghai based Vital Strategic Research Institute (VSRI), has signed an agreement with Eli Lilly and Company. Under the terms of the agreement, VSRI will provide Eli Lilly with an assessment of Cardio Vascular Disease (CVD) among newly diagnosed diabetes patients at increased risk of CVD in China

ELI LILLY AND COMPANY AND SUBSIDIARIES 2016
Financial Highlights>>>> Revenu 2016 $ 21Billion !!! Netto income 2.7Billion

https://en.wikipedia.org/wiki/Eli_Lilly_and_Company

Eli Lilly builds $23B-plus Sales Forecast for 2017 on diabetes, cancer launches
https://www.fiercepharma.com/pharma/facing-cialis-patent-expiration-and-pricing-strife-diabetes-eli-lilly-eyes-new-launches-for

**China spends $50 billion treating diabetes and related diseases every year,
https://blogs.wsj.com/chinarealtime/2016/11/14/chinas-diabetes-problem-from-1-to-10-in-36-years/

**China, about 230 million people have cardiovascular disease.1
http://www.wpro.who.int/china/mediacentre/factsheets/cvd/en/

ELI LILLY AND CO Share price $ 87.00 Not a bad company to work with!!!
https://www.marketwatch.com/investing/stock/lly


DD ABOUT: *1--Vital Strategic Research Institute (VSRI)
https://globenewswire.com/news-release/2017/10/11/1144375/0/en/NSAV-ANNOUNCES-CLOSING-OF-ACQUISITION-OF-SHANGHAI-VITAL-STRATEGIC-MEDICAL-TECHNOLOGY-COMPANY.html
http://www.otcmarkets.com/stock/NSAV/news/Nsav-Announces-Major-Upgrade-of-Shanghai-Vital-Strategic-Medical-Website-and-Significant-Progress-of-Mjcoin?id=171824&b=y
VSRI: webpage
http://vital-strategic.com/
VSRI: address USA and China
http://vital-strategic.com/contact/

*2--- Seven Leaf Technologies offer a wide range of services to the legal cannabis industry,
https://finance.yahoo.com/news/nsav-cannabis-information-technology-division-132000374.html
http://nsavholdinginc.com/seven-leaf-technologies/

*3---MJCOIN WILL BE MINTED ON ETHEREUM BLOCKCHAIN CRESCO
https://www.otcmarkets.com/stock/NSAV/news/NSAV-ANNOUNCES-MJCOIN-WILL-BE-MINTED-ON-ETHEREUM-BLOCKCHAIN?id=172364&b=y

**--MJCOIN PRIVATE PRESALE 1 december FOR ITS LEGAL CANNABIS DIGITAL CURRENCY
https://globenewswire.com/news-release/2017/11/10/1184654/0/en/NSAV-ANNOUNCES-MJCOIN-PRIVATE-PRESALE-FOR-ITS-LEGAL-CANNABIS-DIGITAL-CURRENCY.html


What is a whitepaper in cryptocurrencies?
https://www.quora.com/What-is-a-whitepaper-in-cryptocurrencies

All combined in this holding: NSAV Company Profile:

http://nsavholdinginc.com/company-profile/

Now the value of NSAV-CHIF with TigerHempBeer

Nice clean shell -CHIF- for Tiger Hemp Bear and low S/S ???? $$$$$$$
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136799769